Healthcare provider profile · identity verified

Jane M Davis, MD

Family Practice · FLAGSTAFF, AZ · NPI 1770711178

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	687	177
Atorvastatin Calcium	Atorvastatin Calcium	525	162
Amlodipine Besylate	Amlodipine Besylate	458	131
Losartan Potassium	Losartan Potassium	454	136
Rosuvastatin Calcium	Rosuvastatin Calcium	371	114
Lisinopril	Lisinopril	362	107
Omeprazole	Omeprazole	270	95
Trazodone Hcl	Trazodone Hcl	250	90
Simvastatin	Simvastatin	247	68
Gabapentin	Gabapentin	231	90
Hydrochlorothiazide	Hydrochlorothiazide	215	64
Metoprolol Succinate	Metoprolol Succinate	201	66
Metformin Hcl	Metformin Hcl	198	62
Sertraline Hcl	Sertraline Hcl	177	58
Tamsulosin Hcl	Tamsulosin Hcl	155	51
Famotidine	Famotidine	148	48
Pantoprazole Sodium	Pantoprazole Sodium	147	46
Pravastatin Sodium	Pravastatin Sodium	131	44
Montelukast Sodium	Montelukast Sodium	128	39
Albuterol Sulfate Hfa	Albuterol Sulfate	127	61
Alendronate Sodium	Alendronate Sodium	127	36
Tramadol Hcl	Tramadol Hcl	124	40
Carvedilol	Carvedilol	123	37
Duloxetine Hcl	Duloxetine Hcl	122	40
Prednisone	Prednisone	122	82
Potassium Chloride	Potassium Chloride	120	41
Citalopram Hbr	Citalopram Hydrobromide	104	29
Eliquis	Apixaban	100	35
Allopurinol	Allopurinol	95	29
Warfarin Sodium	Warfarin Sodium	92	25
Furosemide	Furosemide	90	35
Escitalopram Oxalate	Escitalopram Oxalate	88	23
Meloxicam	Meloxicam	87	36
Zolpidem Tartrate	Zolpidem Tartrate	83	30
Atenolol	Atenolol	81	25
Ozempic	Semaglutide	80	13
Fluticasone Propionate	Fluticasone Propionate	78	40
Metformin Hcl Er	Metformin Hcl	77	25
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	75	57
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	19
Estradiol	Estradiol	74	32
Ibandronate Sodium	Ibandronate Sodium	74	31
Synthroid	Levothyroxine Sodium	68	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	18
Paroxetine Hcl	Paroxetine Hcl	60	14
Triamcinolone Acetonide	Triamcinolone Acetonide	60	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Venlafaxine Hcl Er	Venlafaxine Hcl	58	16
Bupropion Xl	Bupropion Hcl	56	18
Ezetimibe	Ezetimibe	55	16
Valacyclovir	Valacyclovir Hcl	54	27
Ipratropium Bromide	Ipratropium Bromide	53	30
Clopidogrel	Clopidogrel Bisulfate	52	17
Donepezil Hcl	Donepezil Hcl	51	21
Azithromycin	Azithromycin	47	41
Incruse Ellipta	Umeclidinium Bromide	47	16
Lorazepam	Lorazepam	45	19
Metoprolol Tartrate	Metoprolol Tartrate	45	15
Nystatin	Nystatin	45	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	34
Finasteride	Finasteride	44	13
Glipizide Er	Glipizide	44	12
Jardiance	Empagliflozin	43	15
Lovastatin	Lovastatin	43	13
Propranolol Hcl	Propranolol Hcl	42	14
Spironolactone	Spironolactone	38	12
Alprazolam	Alprazolam	37	12
Glimepiride	Glimepiride	37	suppressed
Liothyronine Sodium	Liothyronine Sodium	36	suppressed
Trulicity	Dulaglutide	36	12
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	12
Azelastine Hcl	Azelastine Hcl	34	15
Ropinirole Hcl	Ropinirole Hcl	34	11
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	12
Pregabalin	Pregabalin	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Telmisartan	Telmisartan	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	23
Acyclovir	Acyclovir	28	11
Celecoxib	Celecoxib	28	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	26
Glipizide	Glipizide	28	suppressed
Ramipril	Ramipril	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Xarelto	Rivaroxaban	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	12
Doxepin Hcl	Doxepin Hcl	22	11
Ondansetron Hcl	Ondansetron Hcl	22	16
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	11
Nifedipine Er	Nifedipine	18	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Flecainide Acetate	Flecainide Acetate	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	15
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Fluconazole	Fluconazole	15	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Valsartan	Valsartan	15	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Flavoxate Hcl	Flavoxate Hcl	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ofloxacin	Ofloxacin	12	12
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Digoxin	Digoxin	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error